Efficacy of Vonoprazan Based Dual and Triple Therapy for Patient With Helicobacter Pylori Infection
Efficacy of Vonoprazan Based Dual and Triple Therapy for Naive Patient With Helicobacter Pylori Infection
Sohag University
150 participants
May 13, 2025
INTERVENTIONAL
Conditions
Summary
This study aims to assess Efficacy of vonoprazan based dual and triple therapy for naïve patient with Helicopacter Pylori infection in Sohag Government .
Eligibility
Inclusion Criteria2
- Age: >18 years old.
- H. pylori infection: Confirmed by histopathology or non-invasive tests (e.g., stool antigen test).
Exclusion Criteria5
- Prior H. pylori treatment: Previous treatment for H. pylori infection.
- Allergies: Known allergies to study medications or components.
- Patients cannot finish treatment course.
- Patient missed follow up.
- Patients refusing or neglecting test of cure for H. pylori.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
we assess the efficacy of Vonoprazan based dual therapy for eradication of Helicobacter Pylori infection in naive patient.
we assess the efficacy of Vonoprazan based triple therapy for eradication of Helicobacter Pylori infection in naive patient.
we assess the efficacy of PPI based triple therapy for eradication of Helicobacter Pylori infection in naive patient.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07045688